Myonex Closes Creapharm Acquisition Expanding Global Services

Myonex has completed the previously announced acquisition of CREAPHARM’s pharmaceutical services business. This transaction combines capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, including companies managing Advanced Therapies. Creapharm’s clinical packaging and distribution services, commercial packaging operations and bioservices will now be known as Creapharm, a Myonex company. “We are thrilled to have completed the acquisition of Creapharm, a milestone that expands our services and enhances our capabilities for clients and the industry. Together, we are poised to meet the dynamic needs of our clients with agility, flexibility, and reliability,” stated James Lovett, CEO of Myonex.

Read the full article: Myonex Closes Creapharm Acquisition Expanding Global Services //

Source: https://www.prnewswire.com/news-releases/myonex-closes-creapharm-acquisition-expanding-global-services-302134181.html

Leave a Comment

Your email address will not be published.

Scroll to Top